Johnson & Johnson's coronavirus vaccine is showing signs of offering protection in a single dose.
The company has been testing several vaccine contenders on monkeys, and discovered its most effective vaccine produce an immune response and appeared safe in all of them, according to a study published Thursday in the scientific journal Nature. The company will now test the vaccine on humans to determine if it's safe and effective for widespread use.
Johnson & Johnson tested what turned out to be its most viable vaccine on six monkeys, and all of them remained completely safe from lung disease when exposed to the virus. Five of the six remained entirely safe from coronavirus infection when exposed as well. "This gives us confidence that we can test a single-shot vaccine in this epidemic and learn whether it has a protective effect in humans,” Johnson & Johnson's chief scientific officer Dr. Paul Stoffels told Reuters.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
This is the second vaccine proven to be effective in monkeys, Angela Rasmussen, a virologist at Columbia University, noted to The New York Times. But "we can't take shortcuts" and rush into large-scale human trials just because of these results, she cautioned. More than 30 potential COVID-19 vaccines are now undergoing human trials worldwide, though Johnson & Johnson's is one of the few that may only require a single dose and not a follow-up booster shot.
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
